All News

Along with presenting best practices for pharmacies’ vaccination workflows, researchers explore the impact of community pharmacies offering technician-administered vaccines.

Mississippi pharmacies strengthen prenatal care with monthly check-ins, vitamins, aspirin, screenings, and community support for high-risk moms.

In an exploration of the drug stigma scale, researchers assess its ability to address factors associated with stigma levels regarding OTC misuse.

Across the United States, trafficking also takes the form of labor exploitation in farms, factories, and remote industrial regions.

With the OPUS-1, 2, and 3 trials underway, Vax-31 has the potential to become the first pneumococcal vaccine of its kind, demonstrating never-before-seen impacts on disease burden.

MAHA-driven HHS shifts vaccines and nutrition, fueling public health debate as pharmacists battle social media misinformation and rebuild trust.

The FDA clears the highest-dose weekly semaglutide for obesity, showing 20.7% mean weight loss with the same blood sugar-lowering effects.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.

Pharmacists spot subtle abuse and sexual health red flags, avoid profiling, and respond safely with resources while protecting HIPAA privacy.

In Texas community pharmacies, researchers assess the communication concordance between pharmacists and patients during medication counseling.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.

MiniMed Flex is a smaller, screenless, and phone-controlled insulin automation that shows how pharmacists boost AID success for patients with diabetes.

Annie Lambert, PharmD, BCSCP, discusses pharmacies’ regulation and compliance needs when it comes to dispensing compounded GLP-1s.

The new parameter combines waist circumference, hypertension status, and glycated hemoglobin to determine insulin resistance.

FDA approves icotrokinra as a first-line systemic treatment of plaque psoriasis with a targeted oral peptide for adults and pediatric patients.

Many states are pushing pharmacies to move beyond the traditional dispensing role into more robust clinical care.

Investigators used a large cohort of patients from Taiwan between 2004 and 2015 to determine the potential link between Tylenol use and childhood neurodevelopment.

Combined with nutritional interventions, semaglutide also demonstrates greater weight loss compared with dulaglutide.

CDC researchers investigate pneumococcal disease cases and intervention strategies within a North Carolina correctional facility from June 14 to July 30, 2024.

The health care landscape for metabolic liver disease is undergoing a shift, and pharmacists are being positioned at the forefront of this therapeutic revolution.

From proposed transparency rules to Medicare price negotiation programs, the stakes are high for pharmacy reimbursement and the sustainability of independent practices.

The FDA clears secukinumab for patients 12 years and older with tough hidradenitis suppurativa, offering weight-based IL‑17A biologic relief and new guidance on screening and safety.

Annie Lambert, PharmD, BCSCP, discusses the key approaches to ensuring safe and effective dispensing of compounded GLP-1 medications.

From patient perspectives on acceptability, researchers assess the impact of pharmacist-led point-of-care testing services in rural Tennessee communities.

Remote hub model in New Zealand upskills pharmacists to launch automated insulin delivery faster, expanding equitable access for type 1 diabetes.

This landmark decision follows previous approvals for adults 60 years and older, as well as those aged 50 to 59 years at increased risk.

Researchers investigate PCV25 developments and potential use of the vaccine among adults who are healthy and naïve to the pneumococcal vaccine.